AGENDA
InterContinental Dubai Festival City, Dubai
4-5
September 2026
Day 1
Time
Duration
Title
Speaker
07:00 – 07:15 pm
15 Min
Opening and Introduction
Prof. Humaid AlShamsi
07:15 - 07:30 pm
15 Min
Welcome Note by Our Sponsor
AstraZeneca
SESSION 1: Targeting HER2low/Ultralow in mBC
Panelists:
Chairperson: Dr. Emad Anwar
Dr. Basel Altrabulsli, Dr. Faisal Alterkait, Prof. Giuseppe Viale, Prof. Martin Dietrich, Dr. Muhammad Latif, Dr. Salha Bujassoum
7:30 - 07:50 pm
20 Min
Optimizing Endocrine Therapy in HR+/HER2- mBC
Dr. Bassel Jallad
07:50 - 08:10 pm
20 Min
Advancing Diagnostic Precision: From HER2 Low to HER2 Ultra-Low
Prof. Giuseppe Viale
08:10 - 08:35 pm
25 Min
ADCs: Connecting Therapeutic Innovation with Patient Outcome
Prof. Martin Dietrich
08:35 – 08:50 pm
15 Min
Panel Discussion
All Experts
Panelists:
Chairperson: Dr. Hassan Jaafar
Dr. Abdulwahab Altourah, Dr. Khaled Al-Bimani, Dr. Maroun El Khoury, Dr. Nouri Bennini, Prof. Nuhad K. Ibrahim
08:50 - 09:10 pm
20 Min
Chemotherapy Vs ADCs: Shifting the Treatment Paradigm Debate
Dr. Anwar Alnouri
Dr. Saeed Rafii
09:10 - 09:35 pm
25 Min
Clinical Case Discussion I
Panel Discussion
Dr. Dina Hamza
09:35 - 10:00 pm
25 Min
Clinical Case Discussion II
Panel Discussion
Dr. Tarkan Yetisyigit
10:00 - 10:05 pm
5 Min
Closing
Dr. Hassan Jaafar
DINNER
Day 2
Time
Duration
Title
Speaker
08:45 - 09:15 am
30 Min
Registration
09:15 - 09:30 am
15 Min
Opening
AstraZeneca
SESSION 2: HER2+ Early Breast Cancer
Panelists:
Chairperson: Dr. Hassan Jaafar
Dr. Dina Hamza, Prof. Fharat Raja, Dr. Ibrahim Abu-Gheida, Dr. Mawada Hussein, Prof. Nuhad K. Ibrahim, Dr. Ram Singarachari
09:30 - 09:50 am
20 Min
Navigating Treatment Strategies in HER2+ Early BC
Dr. Fathi Azribi
09:50 - 10:10 am
20 Min
Expanding the Use of HER2-Directed ADC into HER2+ Early BC
Prof. Nuhad K. Ibrahim
10:10 - 10:25 am
15 Min
Radiation Oncology and ADCs: New Treatment Perspectives
Dr. Ibrahim Abu-Gheida
10:25 - 10:45 am
20 Min
Clinical Case Discussion I
Panel Discussion
Dr. Dima Abdul Jabbar
10:45 - 11:05 am
20 Min
Clinical Case Discussion II
Panel Discussion
Dr. Faisal Alterkait
11:05 - 11:20 am
15 Min
Coffee Break
SESSION 3: HER2+ Metastatic Breast Cancer
Panelists:
Chairperson: Dr. Bassel Jallad
Dr. Anwar Alnouri, Prof. Fharat Raja, Dr. Hala Abdel Latif, Prof. Martin Dietrich, Dr. Sahar Awad, Dr. Sundus Yahya
11:20 - 11:40 am
20 Min
A New Era in First-Line HER2+ mBC Treatment
Prof. Fharat Raja
11:40 - 12:00 pm
20 Min
Optimizing Patient Care Journey in mBC
AZ Symposium
Dr. Shaheenah Dawood
12:00 - 12:20 pm
20 Min
Clinical Case Discussion I
Panel Discussion
Dr. Dalia Elshorbagy
12:20 - 12:40 pm
20 Min
Clinical Case Discussion II
Panel Discussion
Dr. Emad Anwar
12:40 - 01:00 pm
20 Min
Coffee Break
SESSION 4: Tumor Agnostic Therapy in HER2+ Disease
Panelists:
Chairperson: Dr. Syed Hammad
Dr. Amin Abyad, Dr. Amrou Shaboan, Dr. Cherian Thampy, Dr. Diaeddine Trad, Dr. Mohamed Ashour, Dr. Ram Singarachari
01:00 - 01:15 pm
15 Min
HER2-Targeted ADCs: Moving Beyond Breast Cancer
Dr. Jawaher Ansari
01:15 - 01:30 pm
15 Min
HER2 Expression in Solid Tumors: From Reflex Testing to Treatment Decisions
Prof. Giuseppe Viale
01:30 - 01:45 pm
15 Min
Clinical Case Discussion I
Panel Discussion
Dr. Aref Chehal
01:45 - 02:00 pm
15 Min
Clinical Case Discussion II
Panel Discussion
Dr. Sonia Otsmane
02:00 - 02:15 pm
15 Min
Clinical Case Discussion III
Panel Discussion
Dr. Cherian Thampy
02:15 – 02:30 pm
15 Min
Closing
Lunch
03:30 – 03:45 pm
15 Min
Role of Radiologist in Cancer Care
Prof. Julien Dinkel
03:45 – 05:30 pm
1 Hr 45 Min
Radiology Workshop
Sponsored by AZ
03:30– 05:30 pm
2 Hrs
Pathology Workshop
Sponsored by AZ
